| |
|
|
|
| |
|
|
| Industry
Panel Discussion (TBA) |
|
| |
|
|
|
|
|
|
Invest, Partner and Network with the Most Promising Early- to
Late-Stage Medical Technology Companies and the Biggest Deal
Makers in the Medtech Business Development and Investment Communities
in San Francisco this June
| The
In3 Medical Device Summit
is the most important venue of its kind for previewing
cutting-edge emerging medical technology companies and
for engaging with the biggest dealmakers in the industry,
including senior executives from the device industry and
healthcare investment community, all in a short period
of time. All attendees will benefit from the mix of quality
presentations, speakers, roundtables, workshops and panels
addressing the hottest topics in the ever-more-competitive
and lucrative medical technology marketplace, along with
the unmatched networking and partnering opportunities
that attendees have come to expect from Investment
In Innovation (In3) events over the
past 7 years ...
Benefit
From:
• 60+ early- to late-stage medical technology company
presenters focused into Three Concurrent Tracks:
TRACK
1: Cardio/Peripheral Vascular
TRACK 2: Orthopedics and Spine
TRACK 3: Other High-Growth Technologies
… all seeking financing, M&A, and/or strategic
partnership opportunities.
(Check
back soon for our growing list of presenters and other
event details.)
•
A full program of quality keynote presentations, industry
expert guest speakers, on-stage interviews, workshops
and panels addressing the hottest topics in the worldwide
medical technology marketplace.
•
Networking with hundreds of senior-level decision-makers
from the healthcare investment community and major medical
device and biotech companies.
Presentations
from our hand-selected group of cutting-edge early- to
late-stage companies will encompass a wide variety of
high-growth device sectors, including:
- Cardiovascular
Therapeutics and Diagnostics
-
Diagnostics
- Drug
Delivery
- Imaging
and Image-Guided Surgery
-
Minimally Invasive Surgery
- Nanotechnology
- Neurostimulation
- Oncology
- Orthopedics
and Spine
- Peripheral
Vascular
- Stem
Cells
- Stroke
Management
- Tissue
Engineering
- Wound
Management
...
to mention only a few.
|
|
Advisory Board
Jeffrey
Barnes
General Partner
Oxford Bioscience Partners
Annette
Campbell-White
Senior Managing Member MedVenture Associates
Michael
Carusi
General Partner
Advanced Technology Ventures
Luke
Evnin
General Partner
MPM Capital
Richard
M. Ferrari
Managing Director
DeNovo Ventures
William
T. Harrington
Partner
Three Arch Partners
Ross
A. Jaffe
Managing Director
Versant Ventures
Ellen
Koskinas
Partner
InterWest Partners
Josh
Makower
Venture Partner
NEA
John
Maroney
General Partner
Delphi Ventures
David
Milne
Managing Partner
SV Life Science Advisers
Trevor
J. Moody
Partner
Frazier Healthcare Ventures
Jesse
I Treu
Partner
Domain Associates |
|
| For
more information, please contact Kristy Grimes at 480-985-9512,
888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com |
|
| back to top |
Presenting Companies
| Presenting Companies/
Locations |
Technologies |
| TRACK 1: CARDIOVASCULAR AND PERIPHERAL VASCULAR |
|
Allvivo
Vascular, Inc.
Lake Forest, CA
|
Allvivo
Vascular’s ProteoGuard™ is a biomimetic stent coating that prevents restenosis
without the side effects of drug eluting stents |
| Arterial
Remodeling Technologies (ART)
Noisy le Roi, France |
ART
has developed Biodegradable peripheral and coronary polymer stents that
promote the natural remodelling of the injured artery after angioplasty.
|
| CardiAQ
Valve Technologies (First-Time Presenter)
Winchester, MA |
CVT’s
platform technology will make aortic valve replacement faster, safer,
and less-invasive… without compromising performance |
Cardiola,
Ltd.
Winterthur,
SWITZERLAND
|
(technology
description available soon at http://www.meddevicesummit.com/)
|
Cardiva
Medical, Inc.
Mountain View, CA
|
Minimally
invasive closure that provides early ambulation, lower complications,
reduced cost while leaving nothing behind |
Dialog
Devices, Ltd.
Loughborough, United Kingdom
|
Dialog
Devices presents Padd for peripheral arterial disease assessment in Primary
Care to prevent heart disease and stroke |
Emergence
LLC (First-Time Presenter)
Berkeley,
CA
|
EMERGENCE
LLC helps early stage companies developing polymer intensive technologies
overcome the challenges of the initial start-up phase through funding
and access to an R&D infrastructure.
|
| ES
Vascular Ltd.
Haifa, Israel |
First
ever endovascular staplers approved in the EU for AAA; under further
development for cardio, minimally-invasive and peripheral vascular indications.
|
| Genesis
Medical Interventional, Inc.
Redwood City, CA |
Proximal
Occlusion Funnel Catheter™ for Embolectomy and Thrombectomy & Scoring
Balloon with Drug Delivery Capability. |
Intellwave,
LLC (First-Time Presenter)
Edison, NJ |
Intellwave
- Non-invasive, fully automated system that provides Heart Rate Variability
(HRV) analysis for quantitative assessment of the Autonomic Nervous System
(ANS)
|
Interventional
and Surgical Innovations, LLC
Campbell Hall, NY |
Interventional
Technologies |
| Neochord,
Inc.
(First-Time Presenter)
Wayzata, MN |
NeoChord
is commercializing a Mayo Clinic invention that enables minimally invasive
implantation of artificial chordae tendinea. Artificial “chords” are
frequently used by cardiac surgeons doing mitral valve repair. |
| PROTOMED
Marseille, France |
PROTOMED
develops sutureless devices designed to accelerate peripheral vascular
reconstructions and drive changes in Minimally-Invasive Surgery. |
| Tayside
Flow Technologies Limited
(First-Time Presenter)
Dundee, Scotland |
TFT's
proprietary technology reproduces the naturally occuring form of blood
flow - Spiral Laminar Flow (SLF). Current products and technologies
do not produce SLF, thereby contributing to neo-intimal hyperplasia
and, for example, low patency of bypass grafts; therefore TFT's technology
represents a potential major improvement in clinical outcomes. |
| Thornhill
Research Inc. (First-Time Presenter)
Toronto, Canada |
Diagnostic
products for neuroimaging and cardiology markets including civilian,
military and emergency medicine. |
| Vasorum
Ltd
(First-Time Presenter)
Citywest Dublin, Ireland |
Vasorum
Limited has developed the ideal arterial puncture closure device which
provides immediate hemostasis in a fully anticoagulated environment,
is simple to use, is deployed through the existing sheath and can be
used to close high stick punctures. This device is the first true competitor
to the leading product in this market with potential annual sales of
>$1.5 billion. |
| |
|
| TRACK 2: ORTHOPEDICS AND SPINE |
|
Argo
Medical Technologies Ltd. (First-Time Presenter)
Haifa,
Israel
|
A
wearable, motorized, quasi-robotic suit which enables lower-limb paralysis
victims to stand, walk and even climb stairs |
| Bone
Biologics, Inc.
Beverly Hills, CA |
The
rhUCB-1 is an orthobiologic protein for use in osteoinductive applications
such as spinal fusion and long bone fracture repair. |
Echometrix,
LLC (First-Time
Presenter)
Mt.
Horeb, WI
|
Echometrix
, LLC - Develops proprietary ultrasound systems for real-time, quantitative
evaluation of soft tissue injuries.
|
Emergence
LLC (First-Time Presenter)
Berkeley,
CA |
EMERGENCE
LLC helps early stage companies developing polymer intensive technologies
overcome the challenges of the initial start-up phase through funding
and access to an R&D infrastructure. |
| Innova
Orthopaedics
(First-Time Presenter)
Baltimore, MD |
ARGOS
Technology: completely implantable and adjustable orthopedic device
for deformity correction, cosmetic limb lengthening, and bone fractures
treatment. |
| Orthovita,
Inc.
Malvern, PA |
A
synthetic-based biomaterials company focused on spine and orthopedics.
Orthovita's core technology platforms, Vitoss, Vitagel, and Cortoss
address clinical needs in the repair of bone and soft-tissue. |
| |
|
| TRACK 3: OTHER HIGH-GROWTH TECHNOLOGIES |
|
| AltaScience Limited
(First-Time Presenter)
Citywest Dublin, Ireland
|
AltaScience
has developed a novel transcervical female sterilisation device which
can be easily placed in the fallopian tubes though a hysteroscope. With
only one FDA approved device currently on the market in the US, this
product is targeting a global market with potential sales of >$1
billion annually. |
| Ceragenix
Pharmaceuticals
Denver , CO |
Ceragenix
Pharmaceuticals is developing its "Cerashield" line of antimicrobial
coatings to prevent microbial colonization and biofilm formation of
endotracheal tubes and other indwelling medical devices. |
| CVAC
Systems, Inc.
Temecula, CA |
New
platform device technology for the amelioration of diseases associated
with insulin resistance. The flagship application will be diabetic neuropathy.
70% of type 2 diabetics have measurable neuropathy. |
Envisionier
Medical Technologies (First-Time Presenter)
Rockville, MD
|
(technology
description available soon at http://www.meddevicesummit.com/)
|
| EyeGate
Pharmaceuticals, Inc. (First-Time Presenter)
Waltham, MA |
The
EyeGate® II uses iontophoresis technology to safely and non-invasively
deliver therapeutics for ocular indications. |
| Gel
Delivery Solutions BV (First-Time Presenter)
The Netherlands |
Gel
Delivery Solutions develops an injectable synthetic polymer gel, that
is 100% biodegradable in situ, sets at body temperature and provides
slow release kinetics for proteins over days to months. Specifically
targetted at closed tissue applications such as back-of eye, cranial
and spinal delivery of advanced therapeutics. |
GlucoLight
Corporation
Bethlehem, PA |
GlucoLight
- GlucoLight is developing a continuous, non-invasive glucose monitor
for the implementation of tight glycemic control in the hospitalized patient |
| Healionics
Corporation (First-Time Presenter)
Redmond, WA |
Healionics
develops biomaterials to enhance the biocompatibility and performance
of current and next generation devices. Our core technology, STAR material,
is a precisely engineered synthetic 3D tissue scaffold which promotes
angiogenesis and tissue growth while reducing FBR. |
InfraScan,
Inc.
Philadelphia,
PA
|
Infrascanner
is a cost-effective, handheld medical imaging system for detecting brain
hematomas
|
Interface
Biologics (First-Time Presenter)
Toronto, Canada |
Interface
Biologics’ polymer additive technologies yield superior outcomes for drug-medical
device combination products.
|
| Keraderm
LLC
(First-Time Presenter)
Hampton, VA |
Keraderm
is an early stage medical device company commercializing a phototherapy
treatment for nail fungal infections which is superior in efficacy and
safety to current oral or topical treatments.
|
| MicroPhage, Inc.
Longmont, CO |
Bacteriophage
enabling technology which offers the ability to increase specificity
and decrease time to results on existing immunodiagnostic platforms.
|
MoleMap
(First-Time Presenter)
Auckland, New Zealand
|
MoleMap™
is a tele-medicine application utilising digital imaging and diagnostic
systems that has allowed the establishment of the world’s most comprehensive
melanoma and skin cancer screening program. |
| Nanobiotix
LABEGE CEDEX, France |
New
treatments for cancer based on the combined application of nanotechnologies
and biotechnologies. |
| Novian
Health Inc.
Chicago, IL |
Minimally-invasive procedure for ablation of breast tumors offering
minimal scarring, quicker recovery times, and only requiring local anesthesia.
|
| Photo
Dynamic Therapy
Vienna, Austria |
Clinical
hands-on service with non-invasive tumor treatment modality specific
to patients’ individual need by intelligent laser light and photon transformer |
| Polymedix,
Inc.
(First-Time Presenter)
Radnor, PA |
Novel
anti-microbial polymeric coatings for devices and implants. |
Provista
Life Sciences, LLC
Phoenix, AZ
|
Provista
Life Sciences offers blood tests for breast cancer for Alzheimer’s through
its CLIA Lab |
| Softscope
Medical Technologies
(First-Time Presenter)
Minnetonka , MN |
Softscope
Medical is developing an innovative endoscopic assist device designed
to significantly improve flexible endoscopy procedures. The company’s
first product, a colonoscopy assist device, is designed to reduce procedure
time and make the examination more comfortable for the patient. A device
also under development will make complete small bowel enteroscopy practical
for the first time. |
Stetta
& Secca (First-Time Presenter)
Hercules, CA
|
Stretta and Secca are innovative medical
devices based on the utilization of Radio Frequency Energy tecchnology
that enables patient- friendly procedures for the treatment of Gastrointestinal
Disorders |
Symbios
Medical (First-Time Presenter)
Georgetown, IN
|
The
Symbios GOPump™ Rapid Recovery System provides postoperative pain relief
for patients more effectively than narcotics |
| Tissue
Genetics
Aurora, CO |
A
predictive medicine company with novel technology for diagnosing breast
and ovarian cancer and determining responsiveness to new therapeutics.
|
TruTouch
Technologies (First-Time Presenter)
Albuquerque, NM
|
TruTouch
has developed technology for non-invasive alcohol testing with inherent
biometric identity verification. It is a touch-based measurement requiring
no bodily fluids, represents a significant improvement over present testing
modalities, and makes daily alcohol screening a practical option for workplace
safety applications.
|
| Vironova
AB
(First-Time Presenter)
Nacka, Sweden |
Vironova’s
operations are based on a unique proprietary image analysis technology
which allows highly effective automated virus diagnostic and analysis
for improved control and preparedness against emerging viruses linked
to pandemics and/or bioterrorism. |
|
| |
| The
In3 Medical Device Summit–San Francisco is Medtech Insight
and Windhover Information’s 31st In3 event – find
out for yourself why these first-rate events are considered
the most important venue of their kind for key investors from
around the world interested in the medical device space
Benefits
of Attending:
-
Potential acquirers/funding partners will
able to meet and screen over 60 first-rate investment possibilities
in 3 concurrent Tracks in just 2 well-orchestrated days, via
focused presentations covering their widely varied technologies,
stage of development and testing, potential markets, management
teams, regulatory timeline, patent protection, competitive
strategy, funding needed, among many other key details, and
private break-out sessions, among many other networking opportunities.
- It’s
a fact that medical device start-ups face
intense competition for a finite amount of available capital
funding: The In3 Medical Device Summit–San Francisco
is an ideal setting for emerging company management teams
to meet and impress potential investors, from many of the
heavy-hitting, top-tier device companies and discerning healthcare
investment firms from around the world.
-
All attendees will gain a keen understanding
in a short timeframe of the emerging medical technologies
on course to make a distinct impact on the intensely competitive
and evidence-driven worldwide device industry in the next
few years. Register to attend today and get ready to tap into
the many opportunities about to emerge in the medtech space!
We
have a long and strong track record: Over 1350 emerging medical
technology company presenters and over 7200 attendees have participated
at In3 events over the past 7 years. We are very proud that
many young companies have worked their way up the funding ladder
and into the marketplace via the relationships they formed at
In3 events. Click
here for success stories and testimonials from our past
presenters and attendees.
Attendees
will include:
-
Presidents
- CEOs
- Chairmen
- Venture
Partners
- Managing
Directors
- Vice
Presidents/Directors of Business Development, Marketing, New
Technology, Acquisitions, R & D & Sales
- Senior
Investment Analysts/Managers/Directors
….
from these types of companies:
-
Established medical technology companies from around the world
seeking technology through licensing, partnering and acquisition
to broaden or deepen product lines or build sector strength
- Venture
capitalists and investment bankers, and
- Medical
device, biotech, biopharmaceutical or other company executives
seeking investments or partnerships
The
med device industry is red hot, with the number of deals now
increasing each year, and the worldwide medical device market
is changing and evolving rapidly. In3 Medical Device Summit–San
Francisco is a do-not-miss event for anyone interested in the
best-of-the-best emerging medtech companies from around the
globe: we are expecting a record number of participants, from
both the buy and sell side – hurry and secure your spot
today!
|
| back to top |
Program Agenda
|
Tuesday, June 17, 2008 |
|
6:00
– 8:00 p.m.
Pre-Conference Registration and Reception –
Sunset Court
7:00 -
8:00 p.m.
Top Ten
Tips for Planning your VC Funding and Exit – Twin
Peaks
Hosted
by: Christopher J.P. Velis,
Chairman & CEO, Medical Capital Advisors,
LLC |
|
Day One – Wednesday, June 18, 2008
|
|
7:20
- 8:20 a.m.
Registration and Continental Breakfast
– Sunset Court |
|
8:20
Welcome Address - Twin Peaks |
|
8:30
- 9:30a.m.
Large Company Perspective
How
Large Companies Sustain Growth through M & A and Strategic
Partnerships
Panelists:
David Cassak,
Managing Partner, Windhover Information
(moderator)
Richard Dakers, Vice
President, Franchise Development, Cordis, a Johnson and Johnson
Company
John Kehl, Corporate Vice President,
Strategy and Business Development, Edwards Lifesciences
Corporation
Matthew Jennings, Senior Vice
President, Corporate Development Officer, Teleflex Incorporated
|
| 9:30-9:45 a.m -
AM Break |
|
9:45
– 10:45 a.m.
Early Stage Investing, Financing and Exit
Strategies
What are the Hot Deals Now and in the Future
- Why invest
in certain technologies/clinical spaces
- How VCs
look at deals from a business view
- How can
companies maximize their visibility in front of investors
- What kind
of due diligence should companies do?
- How
important are valuations at an early stage?
- How to
plan the exit strategy
- How to
capitalize on the medtech industry
- Rationale
behind early stage investments
- Picks for
deals of the year and why
Panelists:
Stephen Levin, Executive Editor, Windhover
Information (moderator)
John
Maroney, General Partner, Delphi Ventures
Luke
Evnin, General Partner, MPM Capital
Trevor J. Moody, Partner, Frazier Healthcare
Ventures
John
Lonergan, Partner, Mach Ventures, LP
Kevin
Wasserstein, Managing Director, Versant Ventures
|
|
10:45
- 11:15 a.m. Mid-Morning Break - Sunset
Court |
|
11:15
- 12:40 p.m. Company Presentations and Workshops |
|
Track
1 – Cardio/Peripheral Vascular
Twin Peaks North
11:15am Moderator - The
Medtech Group
11:20 Thornhill Research
Inc.
11:30 Arterial Remodeling Technologies
11:40 Vasorum
Ltd
11:50 Genesis Medical Interventional,
Inc.
12:05pm Moderator -
Knobbe Martens
12:10
CardiAQ Valve Technologies
12:20 Tayside Flow Technologies Limited
12:30 Protomed
|
Track
2 – Orthopedics/Spine
Telegraph Hill
11:15am Moderator - Medical
Capital Advisor
11:20 Emergence LLC
11:30
Orthovita, Inc.
11:40 Bone Biologics, Inc.
11:50
Echometrix, LLC
12:05pm Moderator -
Summit Corp. Partners
12:10 Argo Medical
Technologies
12:20 Innova Orthopaedics
|
Track
3 – Other Innovative Technologies
Twin Peaks
South
11:15am
Moderator - Medmarc & The
Hartford
11:20 Photo Dynamic Therapy
11:30
MicroPhage, Inc.
11:40 Healionics Corporation
11:50 Tissue
Genetics
12:05pm Moderator -
Battelle
12:10 Novian Health,
Inc.
12:20 Nanobiotix
12:30 Softscope Medical
Technologies
|
Workshop Room – Pacific Heights
Workshop 1, 11:15-12:15 pm
Presentation Workshop
Medical
Technology Executives Skills Enhancing Workshop
Creating
Effective Presentations: Tips for Developing, Honing and Enhancing Your
Presentation Skills and Content Development
- What every
VC/investor wants to know
- What key
investment information and data should you include?
- Developing
a consistent, impactful company brand message
- Defining
the message for the target audience
- Creating a
value-based customer/audience proposition
- Clearly
defining the presentation goal
- Opening
with clarity and confidence
- Making key
points clear
- Keeping
audience interest
- Using
visuals to reinforce key messages
- Driving
home the message
- Practical
examples and "dos" & "don't" for your presentation
Speakers:
Dan Roth,
Partner, Standing Stone Partners
Todd Sims, Senior
Partner, Standing Stone Partners
James Miller,
Partner, Standing Stone Partners |
|
12:45
- 1:45 p.m. Luncheon - Ralston Room (first
floor) |
|
1:50
- 5:00 p.m. Company Presentations and Workshops |
|
Track
1 – Cardio/Peripheral Vascular
Twin Peaks North
1:45pm
Moderator - Medmarc & The
Hartford
1:50 ES Vascular Ltd.
2:00 ISI Venous
Valve
2:10 Neochord, Inc.
2:20 Emergence
LLC
2:35pm Moderator -
MDMA
2:40 Cardiola, Ltd.
2:50
Allvivo Vascular, Inc.
3:00 ISI Vena Cava Filter
3:10 Dialog
Devices, Ltd.
3:20 Cardiva Medical, Inc.
3:30 IntelleWave,
LLC.
3:40-4:00pm Mid-Afternoon
Break
|
|
Medtech Insight Conference
Keynote
Address |
Telegraph
Hill
3:00-4:00
Access to
high-resolution brain activity with a non-invasive
probe
Presented by:
NeuroVigil, Inc.
NeuroVigil is at the
confluence of neurotechnology and wireless technology and is poised to
usher the world into the realm of personalized preventive medicine. The
company is targeting the sleep, transportation and pharmaceutical
industries.
Speakers:
Dr. Philip Low,
Founder, Chairman, CEO, NeuroVigil, Inc.
|
Track
3 – Other Innovative Technologies
Twin Peaks South
1:45pm Moderator - Summit
Corporate
1:50 Keraderm LLC
2:00 Polymedix, In c.
2:10 Vironova AB
2:20 Gel Delivery Solutions BV
2:35pm Moderator - The
Medtech Group
2:40 EyeGate Pharmaceuticals, Inc.
2:50 AltaScience
3:00 GlucoLight Corporation
3:10 Symbios Medical
3:20 MoleMap
3:30 InfraScan, Inc.
3:40-4:00pm Mid-Afternoon Break
4 :05pm Moderator - Knobbe Martens
4:10 Provista Life Sciences, LLC
4:20 Ceragenix Pharmaceuticals
4:30 Envisionier Medical Technologies
4:40 TruTouch Technologies
4:50 CVAC Systems, Inc.
5:00 Interface Biologics
5:10 Stetta & Secca
|
Workshop Room – Pacific Height
Presentation
Worshop
2:00-3:00 pm
The
Impact Of Recent Patent Infringement Decisions And Litigation Outcomes On
Your Medical Device Company
Presented by: Knobbe Martens Olson
& Bear LLP
The Court of
Appeals for the Federal Circuit issued rulings in 321 patent cases in the
Court's FY 2007. But for the early stage medical device company, only a
few have a direct impact on day to day offensive or defensive patent
strategy . An interactive panel of former Federal Circuit law clerks will
present commentary on some of the most important case decisions, and how
they may affect business decisions in the medical device
industry.
Speakers:
David Ruschke, Chief
Patent Counsel, Medtronic Vascular, Inc.
Gerard von
Hoffmann, Patent Strategy Partner, Knobbe Martens Olson &
Bear LLP
Joseph Re, Litigation Partner, Knobbe Martens
Olson & Bear LLP |
|
5:20
- 5:50 p.m. Sponsored Cocktail Reception - Sunset
Court
5:50-7:15
p.m. Presenting Company Product Exhibition/Networking Reception -
Ralston Room (first Floor) |
|
Day Two - Thursday, June 19,
2008 |
|
8:00
- 9:00a.m.
Registration and Continental Breakfast -
Sunset Court |
|
9:00-9:45am
State of the
Device Industry Address
A Market Analysis of Where Medical
Technology Companies are Going
David
Cassak, Managing Partner, Windhover Information
- Hot
clinical areas: What are they and what are the new emerging
markets?
- M & A:
What are the most important deals of the year and future trends?
- IPOs and
device stocks: Who are the winners and losers, and what does the rest of
the year look like?
- Device
deal structures and valuations: What are the trends?
- Who is
getting funding and what are the new financing models?
- What are
some growth strategies for device companies-small, medium and
large?
|
|
9:45
a.m. – 11:00am
Emerging Markets for Medical Devices: Mining China for
Potential Investments
Identifying Potential Device Opportunities in an Exploding
Market
- What is
the market potential for device companies in China?
- Understanding the competitive landscape, regulatory, due
diligence, business structure and IP issues
- Evaluating
methods and pros/cons of expanding to China?
- What are
some examples and case studies of successful device expansion in these
emerging markets?
- What are
some suggested growth strategies for device companies interested in
China?
Panelists:
Tom Salemi, Windhover Information
(moderator)
Immanuel Thangaraj, Managing Director, Essex
Woodland Health Ventures
Dr.
Nancy Chang, Managing Director, OrbiMed
Carin
Fradin, Executive Director, Global Healthcare Group,
UBS
Michael Yi Zhang, Ph.D., Chairman, Otsuka (China)
Investment Co. Ltd. |
| 11:00-11:15 a.m. Morning Break Sunset
Court |
|
11:15
– 12:15 p.m.
Real-life Case Studies of Successful Financings: How to be
Successful in the Start-Up Trenches
Panelists:
Stephen Levin, Executive Editor,
Windhover Information (moderator)
Kern
Bhugra, CEO, Tibion
Marc
Viscogliosi, CEO, Paradigm Spine
Thomas
Clement, President & CEO, Pathway Medical Technologies, Inc.
|
| 12:15 p.m.
Box Lunch - Sunset Court |
|
12:15
p.m. Conference
Concludes |
Note:
Program subject to change; check back for regular updates.
|
*Cancellation
Policy: The last day to cancel your registration for
a refund, minus a $300 processing fee, is May
16, 2008. After that, you may send another delegate from your
company |
|
Sponsored
by:
Major
Supporting Publication
|
|
